New UKRI proof-of-concept funding set to bolster innovation
Posted:
UKRI unveils a new £9 million proof-of-concept fund to help convert world-class research into market-leading products and services.
The new initiative announced by the UK’s major public funder of research and innovation follows an independent review of university spin-outs, published in November 2023.
The Bacillus Calmette-Guérin (BCG) vaccine prevents severe forms of tuberculosis (TB) and is the world’s most widely used vaccine, as well as the oldest vaccine still in use.
Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us